UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011180 |
|---|---|
| Receipt number | R000013023 |
| Scientific Title | Randomized phase II study of two induction treatments of melphalan, prednisolone, plus bortezomib, JCOG-MPB versus modified PETHEMA-MPB, in elderly patients or non-elderly patients refusing transplant with untreated symptomatic myeloma(JCOG1105, IMPROVE-MPB study) |
| Date of disclosure of the study information | 2013/07/12 |
| Last modified on | 2022/08/30 17:18:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/07/12 10:24:42 | ||
| 2 | Update | 2016/05/11 19:21:08 | Recruitment status |
|
| 3 | Update | 2022/08/27 17:30:10 | Recruitment status Date of IRB |
|
| 4 | Update | 2022/08/27 17:47:11 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 5 | Update | 2022/08/29 09:29:44 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization1 Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 6 | Update | 2022/08/30 17:18:13 | Date of IRB |
